Two Indian Healthcare Companies Jointly Steps in M&A Deals
US-based generic drug maker Mylan Inc is going to pay USD 1.6 billion plus potential additional consideration of up to […]
Say something
Tags: bangalore, Business/Finance, CEO, Clinical Research, food and drug administration, Generic drug, Health/Medical/Pharmaceuticals, injectable products, M&A, marketable injectable products, mumbai, Mylan, Mylan Inc., pharmaceutical, Pharmaceutical sciences, Pharmacology, Second Stock Issuance, Strides Arcolab, Strides Arcolab Ltd, USD
Strides Arcolab gets USFDA approval for anti-bacterial injection
Drug firm Strides Arcolab said it has received the US health regulator’s approval to market injectable Clindamycin USP, used in […]
-
-
Flipkart Health+ App Launched
06-04-2022
